Yahoo Αναζήτηση Διαδυκτίου

Αποτελέσματα Αναζήτησης

  1. 1 Ιαν 2018 · Characterization of coagulase-negative staphylococcal isolates from blood with reduced susceptibility to glycopeptides and therapeutic options

  2. One of the hallmarks of S. aureus is its ability to coagulate blood , allowing for clinical differentiation of S. aureus from coagulase-negative Staphylococci (CoNS) such as S. epidermidis . S. aureus secretes two soluble coagulases that interact with prothrombin to catalyze conversion of fibrinogen to fibrin ( McAdow et al., 2012b ).

  3. The coagulase-positive staphylococci constitute the most pathogenic species S aureus. The coagulase-negative staphylococci (CNS) are now known to comprise over 30 other species. The CNS are common commensals of skin, although some species can cause infections.

  4. S. aureus secretes two proteins that promote coagulation, coagulase (Coa) and von Willebrand factor binding protein (vWbp). Both of these proteins activate prothrombin nonproteolytically [ 26 , 27 ].

  5. Results. Compared to the conventional microbiology testing the real‐time PCR assay had a higher detection rate for both S. aureus and coagulase‐negative Staphylococci (CoNS; 55 vs. 32 for S. aureus and 63 vs. 24 for CoNS). Hands‐on time preparing DNA, carrying out the PCR, and evaluating results was less than 5 h. Conclusions.

  6. 5 Αυγ 2010 · Clinical isolates of the human pathogen Staphylococcus aureus secrete coagulase (Coa), a polypeptide that binds to and activates prothrombin, thereby converting fibrinogen to fibrin and promoting clotting of plasma or blood. Another secreted coagulase, designated von-Willebrand factor binding protein (vWbp), catalyzes a similar reaction.

  7. 1 Ιαν 2018 · Staphylococcal coagulases (Coa, vWbp) are secretory proteins that cause blood clotting through the activation of prothrombin. Based on their ability to clot plasma staphylococci, they may be divided into coagulase-positive or coagulase-negative ones.

  1. Γίνεται επίσης αναζήτηση για